Nice | Ticagrelor for the treatment of acute coronary syndrome ACS

4th November 2011 by Louise Hudman

Ticagrelor is a PO drug which inhibits platelet aggregation. In combination with aspirin it is more effective than clopidogrel + aspirin at reducing the endpoint of MI or death from vascular events.

It will be started by secondary care and continued by cardiologists, so we shouldn’t really have to initiate it.

It will be started in patients who’ve had a STEMI where primary percutaneous coronary intervention (PCI) is considered and also in patients with a NSTEMI who have certain other risk factors.

Read more

No credit card details needed – it takes two minutes.

Join free trial

Login

Already a member? Login to view this content.

Login

"LocumDeck provides a one-stop, easy, pragmatic way to book, invoice and control my GP locum sessions. It cuts out unnecessary dealings with profit-making locum agencies. NASGP provides a wonderful resource to support GP locums above and beyond LocumDeck including informative videos on all aspects of GP locuming including pensions, NASGP Locum Chambers, CPD and more. "

Dr Mike Woodbridge, GP, Lancashire

See the full list of features within our NASGP membership plans

Membership